Status: current, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3637619010 | Acalabrutinib | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3637620016 | Acalabrutinib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Acalabrutinib | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Acalabrutinib | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Acalabrutinib | Is a | Benzimidazole | true | Inferred relationship | Some | ||
| Acalabrutinib | Has disposition | Non-specific protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Acalabrutinib | Is a | Non-specific protein-tyrosine kinase inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Acalabrutinib only product | Has active ingredient | True | Acalabrutinib | Inferred relationship | Some | 1 |
| Acalabrutinib only product in oral dose form | Has active ingredient | True | Acalabrutinib | Inferred relationship | Some | 1 |
| Acalabrutinib-containing product | Has active ingredient | True | Acalabrutinib | Inferred relationship | Some | 1 |
| Acalabrutinib-containing product in oral dose form | Has active ingredient | True | Acalabrutinib | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR